$73.26
1.13[1.57%]
At close: Apr 26
$73.26
0[0.00%]
After Hours: 4:20PM EDT
Intra-Cellular Therapies
(NASDAQ:ITCI)Intra-Cellular Therapies Stock (NASDAQ:ITCI), Insider Trading Activity
Intra-Cellular Therapies: Insider buying and selling updated today.
Shares Outstanding
105.355M%
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 11, 2024 | Sharon Mates | CHAIRMAN, PRESIDENT & CEO | -40.712K | $66.07 | -$4.05M | SELL | -3.73% | 1.050309M | Mar 07 - Mar 11 | View |
| Mar 11, 2024 | Lawrence J Hineline | SVP FINANCE, CFO | -13.132K | $61.53 | -$1.28M | SELL | -100.00% | 0 | Mar 07 - Mar 11 | View |
| Mar 11, 2024 | Michael Halstead | EVP AND GENERAL COUNSEL | -13.132K | $66.09 | -$1.35M | SELL | -100.00% | 0 | Mar 07 - Mar 11 | View |
| Mar 11, 2024 | Mark Neumann | EVP, CHIEF COMMERCIAL OFFICER | -13.132K | $66.23 | -$1.36M | SELL | -30.66% | 29.7K | Mar 07 - Mar 11 | View |
| Mar 11, 2024 | Suresh Durgam | EVP, CHIEF MEDICAL OFFICER | -2.817K | $66.21 | -$672.79K | SELL | -12.45% | 19.803K | Mar 07 - Mar 11 | View |
| Feb 28, 2024 | ROBERT NOSTRAND VAN | 0 | $45.75 | -$1.09M | SELL-OPTIONS | 0.00% | 9.611K | Feb 27 | View | |
| Feb 27, 2024 | Michael Halstead | EVP AND GENERAL COUNSEL | 0 | $69.53 | -$549.78K | SELL-OPTIONS | 0.00% | 0 | Feb 23 - Feb 26 | View |
| Feb 27, 2024 | Lawrence J Hineline | SVP FINANCE, CFO | 0 | $53.16 | -$708.97K | SELL-OPTIONS | 0.00% | 0 | Feb 23 - Feb 26 | View |
| Feb 27, 2024 | Sharon Mates | CHAIRMAN, PRESIDENT & CEO | 0 | $69.79 | -$1.58M | SELL-OPTIONS | 0.00% | 1.050309M | Feb 23 - Feb 26 | View |
| Feb 27, 2024 | Suresh Durgam | EVP, CHIEF MEDICAL OFFICER | 3.795K | $70.17 | -$288.53K | SELL-OPTIONS | 66.66% | 9.488K | Feb 23 - Feb 26 | View |
| Feb 27, 2024 | Mark Neumann | EVP, CHIEF COMMERCIAL OFFICER | 0 | $70.13 | -$554.49K | SELL-OPTIONS | 0.00% | 29.7K | Feb 23 - Feb 26 | View |
| Feb 27, 2024 | JOEL MARCUS | 10.429K | $58.81 | -$9.58K | SELL-OPTIONS | 26.58% | 49.662K | Feb 26 | View | |
| Feb 05, 2024 | Michael Halstead | EVP AND GENERAL COUNSEL | 0 | $66.42 | -$787.72K | GRANT | 0.00% | 0 | Feb 01 - Feb 02 | View |
| Feb 05, 2024 | Sharon Mates | CHAIRMAN, PRESIDENT & CEO | 0 | $67.07 | -$2.27M | GRANT | 0.00% | 1.050309M | Feb 01 - Feb 02 | View |
| Feb 05, 2024 | Mark Neumann | EVP, CHIEF COMMERCIAL OFFICER | 0 | $67.15 | -$796.37K | GRANT | 0.00% | 29.7K | Feb 01 - Feb 02 | View |
| Feb 05, 2024 | Lawrence J Hineline | SVP FINANCE, CFO | 0 | $66.62 | -$745.04K | GRANT | 0.00% | 0 | Feb 01 - Feb 02 | View |
| Feb 05, 2024 | Suresh Durgam | EVP, CHIEF MEDICAL OFFICER | 5.693K | $67.19 | -$414.35K | GRANT | ∞ | 5.693K | Feb 01 - Feb 02 | View |
| Jan 18, 2024 | Sharon Mates | CHAIRMAN, PRESIDENT & CEO | 0 | $41.56 | -$9.45M | SELL-OPTIONS | 0.00% | 1.050309M | Jan 16 - Jan 18 | View |
| Jan 12, 2024 | Michael Halstead | EVP AND GENERAL COUNSEL | 0 | $40.22 | -$2.66M | SELL-OPTIONS | 0.00% | 0 | Jan 11 | View |
FAQ
Is Insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.